AI + Digital Maturity in Contract Manufacturing
Exclusive Report

CDMO Periodic Table

Download

CDMO Live Europe 2026 Early Bird

Agenda Download

CDMO News

3PBIOVIAN Secures French CIR Certification for Finland and Spain Sites Until 2027

BioMatrix Healthcare Acquires Vadodara Greenfield API Facility

Frontage Laboratories Brings New GMP Manufacturing Facility Fully Online for Phase III and Commercial Supply

Agno Pharma Acquires Actylis Eugene Site

Kindeva Appoints David Stevens as CEO Effective January 2026

Zydus Lifesciences Launches Zylidac Bio LLC Following Agenus Transaction Closure

Vetter Advances V-OVS® Next Towards 2027 Commercial Launch

Samsung Biologics Announces CDMO Expansion Plan at J.P. Morgan Healthcare Conference

Celltrion Outlines Plans For Up to 16 IND Filings By 2028

Phlow Corp. Advances AI-driven API Manufacturing with Enveda Collaboration

Fresenius Kabi Partners with TQ Therapeutics to Scale Cell Therapy Manufacturing

More CDMO News

BioMatrix Healthcare Acquires Vadodara Greenfield API Facility

Frontage Laboratories Brings New GMP Manufacturing Facility Fully Online for Phase III and Commercial Supply

Agno Pharma Acquires Actylis Eugene Site

Kindeva Appoints David Stevens as CEO Effective January 2026

Zydus Lifesciences Launches Zylidac Bio LLC Following Agenus Transaction Closure

Vetter Advances V-OVS® Next Towards 2027 Commercial Launch

Samsung Biologics Announces CDMO Expansion Plan at J.P. Morgan Healthcare Conference

Celltrion Outlines Plans For Up to 16 IND Filings By 2028

Phlow Corp. Advances AI-driven API Manufacturing with Enveda Collaboration

Fresenius Kabi Partners with TQ Therapeutics to Scale Cell Therapy Manufacturing

More CDMO News

SPOTLIGHT

How Are You and Your Peers Navigating Pharma Manufacturing in 2026? [Survey]

Ophtapharm in 60 Seconds

RESOURCES

CDMO News

CDMO News

3PBIOVIAN Secures French CIR Certification for Finland and Spain Sites Until 2027

3PBIOVIAN Secures French CIR Certification for Finland and Spain Sites Until 2027

BioMatrix Healthcare Acquires Vadodara Greenfield API Facility

Frontage Laboratories Brings New GMP Manufacturing Facility Fully Online for Phase III and Commercial Supply

Agno Pharma Acquires Actylis Eugene Site

Kindeva Appoints David Stevens as CEO Effective January 2026

Zydus Lifesciences Launches Zylidac Bio LLC Following Agenus Transaction Closure

Vetter Advances V-OVS® Next Towards 2027 Commercial Launch

Samsung Biologics Announces CDMO Expansion Plan at J.P. Morgan Healthcare Conference

Celltrion Outlines Plans For Up to 16 IND Filings By 2028

Phlow Corp. Advances AI-driven API Manufacturing with Enveda Collaboration

Fresenius Kabi Partners with TQ Therapeutics to Scale Cell Therapy Manufacturing

BioMatrix Healthcare Acquires Vadodara Greenfield API Facility

Frontage Laboratories Brings New GMP Manufacturing Facility Fully Online for Phase III and Commercial Supply

Agno Pharma Acquires Actylis Eugene Site

Kindeva Appoints David Stevens as CEO Effective January 2026

Zydus Lifesciences Launches Zylidac Bio LLC Following Agenus Transaction Closure

Vetter Advances V-OVS® Next Towards 2027 Commercial Launch

Samsung Biologics Announces CDMO Expansion Plan at J.P. Morgan Healthcare Conference

Celltrion Outlines Plans For Up to 16 IND Filings By 2028

Phlow Corp. Advances AI-driven API Manufacturing with Enveda Collaboration

Fresenius Kabi Partners with TQ Therapeutics to Scale Cell Therapy Manufacturing

How Are You and Your Peers Navigating Pharma Manufacturing in 2026? [Survey]

Ophtapharm in 60 Seconds

How CDMO Pricing Works [Download]

AI + Digital Maturity in Contract Manufacturing: CDMO Benchmarking Report

North American CDMO Landscape 2025 [Infographic]

Welcome to PharmaSource

Follow us

Top Links

Get in touch